| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132aa5ddba376cda52c2bedb26765245 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08 |
| filingDate |
2001-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3ebf93bca6439c296dced50e3e86d06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_287bf04bc6ab0f97d9bdd762cf7ed707
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_764844f7463d71c3dfcc8d424ea88157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc3ba3d6b3c861d430a23e2fbcb33cbc |
| publicationDate |
2010-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7799770-B2 |
| titleOfInvention |
Solid body forms of mesoprogestin 11β-{4E-(hydroxyiminomethyl)-phenyl}-17α methoxymethyl-17β-methoxy-estra-4,9-dien-3-one |
| abstract |
The invention relates to novel solid body forms of mesoprogestin 11β-[4E-(hydroxyiminomethyl)-phenyl]-17α-methoxymethyl-17β-methoxy-estra-4,9-dien-3-one (oxime J 867), particularly a highly pure and stable amorphous or highly crystalline form (ansolvate/anhydrate) of compound J 867. The invention also relates to methods for producing said novel solid body forms and to the use thereof in pharmaceutical compositions. The novel solid body forms are characterized by exhibiting a high degree of stability. The solid body forms of oxime J 867 can, in particular, be used in the area of fertility control and in hormone replacement therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9109004-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9102701-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9156877-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9085603-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096640-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096639-B2 |
| priorityDate |
2000-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |